389 related articles for article (PubMed ID: 20922765)
1. Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea.
Tripathi A; Jerrell JM; Stallworth JR
Pediatr Blood Cancer; 2011 Jan; 56(1):90-4. PubMed ID: 20922765
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea in very young children with sickle cell anemia is not a cure-all.
Powars DR
J Pediatr; 2001 Dec; 139(6):763-4. PubMed ID: 11743496
[No Abstract] [Full Text] [Related]
3. Hydroxyurea in children: present and future.
Vichinsky EP
Semin Hematol; 1997 Jul; 34(3 Suppl 3):22-9. PubMed ID: 9317198
[TBL] [Abstract][Full Text] [Related]
4. Hydroxurea and sickle cell disease: Its been a long, long time coming.
Scott JP
Pediatr Blood Cancer; 2010 Feb; 54(2):185-6. PubMed ID: 19908298
[No Abstract] [Full Text] [Related]
5. Hydroxyurea for the treatment of sickle cell anemia.
Platt OS
N Engl J Med; 2008 Mar; 358(13):1362-9. PubMed ID: 18367739
[No Abstract] [Full Text] [Related]
6. Low fixed-dose hydroxyurea in severely affected Indian children with sickle cell disease.
Jain DL; Sarathi V; Desai S; Bhatnagar M; Lodha A
Hemoglobin; 2012; 36(4):323-32. PubMed ID: 22734586
[TBL] [Abstract][Full Text] [Related]
7. Use of hydroxyurea in children with sickle cell disease: what comes next?
Ohene-Frempong K; Smith-Whitley K
Semin Hematol; 1997 Jul; 34(3 Suppl 3):30-41. PubMed ID: 9317199
[TBL] [Abstract][Full Text] [Related]
8. DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea.
Friedrisch JR; PrĂ¡ D; Maluf SW; Bittar CM; Mergener M; Pollo T; Kayser M; da Silva MA; Henriques JA; da Rocha Silla LM
Mutat Res; 2008 Jan; 649(1-2):213-20. PubMed ID: 17988936
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.
Obaro SK
Lancet Glob Health; 2015 Mar; 3(3):e124-5. PubMed ID: 25701988
[No Abstract] [Full Text] [Related]
10. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia.
Wang WC; Wynn LW; Rogers ZR; Scott JP; Lane PA; Ware RE
J Pediatr; 2001 Dec; 139(6):790-6. PubMed ID: 11743503
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
Anderson N
Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyurea in Pediatric Patients With Sickle Cell Disease: What Nurses Need to Know.
Rees AL
J Pediatr Oncol Nurs; 2016 Sep; 33(5):339-44. PubMed ID: 26611755
[TBL] [Abstract][Full Text] [Related]
13. [Effect of hydroxyurea on hemoglobin S].
Torres AF; Eberle SE; Sciuccati G; Bonduel M
Medicina (B Aires); 2003; 63(2):140-2. PubMed ID: 12793083
[TBL] [Abstract][Full Text] [Related]
14. The clinical care of adult patients with sickle cell disease.
Olujohungbe A; Howard J
Br J Hosp Med (Lond); 2008 Nov; 69(11):616-9. PubMed ID: 19069260
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea for sickle cell anemia.
Bachmeyer C; Aractingi S; Lionnet F
N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18609755
[No Abstract] [Full Text] [Related]
16. Hydroxyurea use in patients with sickle cell disease in a Medicaid population.
Ritho J; Liu H; Hartzema AG; Lottenberg R
Am J Hematol; 2011 Oct; 86(10):888-90. PubMed ID: 21922530
[No Abstract] [Full Text] [Related]
17. Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome.
Brachet C; Azzi N; Demulder A; Devalck C; Gourdin A; Gulbis B; Klein A; Le PQ; Loop M; Sariban E; Ferster A
Bone Marrow Transplant; 2004 Apr; 33(8):799-803. PubMed ID: 14767501
[TBL] [Abstract][Full Text] [Related]
18. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
Vicari P; Barretto de Mello A; Figueiredo MS
Am J Hematol; 2005 Mar; 78(3):243-4. PubMed ID: 15726590
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists.
Zumberg MS; Reddy S; Boyette RL; Schwartz RJ; Konrad TR; Lottenberg R
Am J Hematol; 2005 Jun; 79(2):107-13. PubMed ID: 15929107
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyurea therapy for diverse pediatric populations with sickle cell disease.
Rogers ZR
Semin Hematol; 1997 Jul; 34(3 Suppl 3):42-7. PubMed ID: 9317200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]